Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GUC-H82E9 | Human | Biotinylated Human GUCY2C / Guanylyl cyclase C Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
GUC-C5255 | Cynomolgus | Cynomolgus GUCY2C / Guanylyl cyclase C Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
GUC-C52H6 | Cynomolgus | Cynomolgus GUCY2C / Guanylyl cyclase C Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GUC-M5254 | Mouse | Mouse GUCY2C / Guanylyl cyclase C Protein, Fc Tag | ![]() |
![]() ![]() |
|
GUC-M52H3 | Mouse | Mouse GUCY2C / Guanylyl cyclase C Protein, His Tag | ![]() |
![]() ![]() |
|
GUC-H82F8 | Human | Biotinylated Human GUCY2C / Guanylyl cyclase C Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
GUC-HF2H8 | Human | FITC-Labeled Human GUCY2C / Guanylyl cyclase C Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GUC-H52H5 | Human | Human GUCY2C / Guanylyl cyclase C Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GUC-H5257 | Human | Human GUCY2C / Guanylyl cyclase C Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
2e5 of Anti-GUCY2C CAR-293 cells were stained with 100 μL of 1 μg/mL of FITC-Labeled Human GUCY2C, His Tag (Cat. No. GUC-HF2H8) and negative control protein respectively, FITC signal was used to evaluate the binding activity(QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Plecanatide | SP-304; GCRA | Approved | Synergy Pharmaceuticals | Trulance | United States | Constipation; Chronic idiopathic constipation | s:21:"Salix Pharmaceuticals"; | 2017-01-19 | Constipation; Irritable Bowel Syndrome; Chronic idiopathic constipation | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Dolcanatide | SP-333; WU-977T914K | Phase 2 Clinical | Synergy Pharmaceuticals | Constipation | Details |
This web search service is supported by Google Inc.